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Abstract
Sleep disorders and nightmares are core symptoms of post-
traumatic stress disorder (PTSD). The relationship seems to 
be bidirectional, and persistent disturbed sleep may influ-
ence the course of the disorder. With regard to sleep quality, 
insomnia and nocturnal anxiety symptoms, as well as night-
mares and stressful dreams, are the most prominent sleep 
symptoms. Polysomnographic measurements reveal altera-
tions of the sleep architecture and fragmentation of rapid 
eye movement sleep. In addition, sleep disorders, such as 
sleep-related breathing disorders and parasomnias are fre-
quent comorbid conditions. The complex etiology and 
symptomatology of trauma-related sleep disorders with fre-
quent psychiatric comorbidity require the application of 
multimodal treatment concepts, including psychological 
and pharmacological interventions. However, there is little 
empirical evidence on the effectiveness of long-term drug 
treatment for insomnia and nightmares. For nondrug inter-
ventions, challenges arise from the current lack of PTSD-
treatment concepts integrating sleep- and trauma-focused 
therapies. Effective therapy for sleep disturbances may con-
sequently also improve well-being during the day and prob-
ably even the course of PTSD. Whether early sleep interven-
tions exert a preventive effect on the development of PTSD 
remains to be clarified in future studies.
© 2021 The Author(s).
Published by S. Karger AG, Basel
Introduction
For more than 3 decades, sleep disorders have been 
classified among the core symptoms of post-traumatic 
stress disorder (PTSD) [1]. According to the DSM-5 cri-
teria, a diagnosis of PTSD requires exposure to a trau-
matic event of catastrophic intensity or an extraordinary 
threat [2]. In addition, the symptomatology of PTSD is 
conceptualized within the framework of 4 symptom clus-
ters, with nightmares being classified as an “intrusion 
symptom” and insomnia as an “alteration in arousal and 
reactivity.” Typically, symptoms occur with a latency of 
several weeks to months after the trauma. The present 
review provides an updated overview of the characteris-
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tics of sleep disorders related to PTSD and traumatiza-
tion, including an overview of psychological and pharma-
cological interventions. Moreover, it highlights the sig-
nificance of sleep disorders as important therapeutic 
target symptoms and also as risk and prognostic factors 
of PTSD.
Bidirectional Relationship
Studies in recent years have expanded upon the clas-
sic model of PTSD; namely in considering sleep disor-
ders as symptoms of PTSD insofar as sleep seems to be 
of major importance regarding the development and 
course of the disorder. This relationship between PTSD 
and sleep disorders is suggested to be bidirectional [3]. 
It has also been shown that pretraumatically disturbed 
sleep may be a risk factor for later developing PTSD 
[4–7]. In addition, insomnia symptoms that occur im-
mediately after a trauma may be predictive for PTSD [8, 
9]. Pronounced sleep disturbances in PTSD also repre-
sent an important prognostic factor for the outcome, as 
they may increase the severity of the condition and 
thus, significantly impair quality of life and daily func-
tioning [10], in addition to increasing risk of alcohol 
and drug misuse [11]. Disturbed sleep may also persist 
despite the improvement of other PTSD symptoms 
[12–14], which may promote the maintenance of PTSD 
over the course of the disorder [15, 16]. Conversely, ef-
fective treatment of sleep disorders and nightmares 
may lead to a clinically significant decrease in PTSD 
symptoms during the day [17–19]. A recent study re-
ported that in individuals with PTSD, sleep duration, 
trouble falling asleep, and difficulties staying asleep the 
prior night predict PTSD symptom severity the next 
day [20]. Accordingly, interventions that enable people 
to sleep better are likely to be of particular therapeutic 
importance, as they may have an immediate remedial 
effect on PTSD symptoms.
Subjective Sleep
Current epidemiological studies suggest that over 90% 
of patients with PTSD suffer from clinically relevant sleep 
disorders [21]. In particular, difficulties falling and stay-
ing asleep as well as post-traumatic nightmares lead to 
irritability and exhaustion during the day and can impair 
emotional processing [22]. In addition, fear of the dark, 
lying awake at night ruminating about the trauma [23], 
talking or screaming during sleep, and waking up disori-
entated may also frequently occur [3].
Insomnia
Insomnia symptoms, that is, difficulty initiating or 
maintaining sleep is reported in 35–61% of patients with 
PTSD; various factors such as comorbidities, different 
criteria for insomnia diagnosis across classification sys-
tems, or trauma type may influence the broad range of 
prevalence estimates [24]. PTSD often leads to acute in-
somnia with behavioral and cognitive symptoms. Perpet-
uating factors (e.g., poor sleep hygiene) and a state of hy-
perarousal may contribute to the maintenance and exac-
erbation of insomnia [24]. Fear of sleep is thought to play 
an important role in the development and maintenance 
of trauma-associated insomnia in the context of PTSD 
and sleep disturbances [25]. According to a recent model 
by Werner et al. [25], PTSD symptoms such as negative 
beliefs about safety and loss of control or re-experiencing 
the trauma (including nightmares) increase the fear of 
sleep. The hyperarousal symptoms, including insomniac 
complaints, in turn favor the emergence of insomnia-re-
lated maladaptive processes and therefore, contribute to 
the maintenance of insomnia. Avoidance behavior is like-
ly to contribute to the maladaptive processes of both 
pathways and thus, has an equally reinforcing influence 
[25]. Treatment of fear of sleep could be integrated into 
both trauma-focused and sleep-focused approaches [25]. 
It remains unclear whether treatment-resistant insomnia 
[12–14] may also be due to lack of adequate consideration 
of fear of sleep.
Post-Traumatic Nightmares
Frightening post-traumatic nightmares occur in up to 
67% of patients with PTSD [26] and may have a signifi-
cant effect on the emotional state the following day. The 
spectrum of post-traumatic dreams ranges from trauma-
related dreams to nightmares in which the trauma is re-
experienced [27]. The different subtypes are summarized 
in Table 1.
While nightmares without a traumatic cause typically 
occur in the second half of the night and are associated 
with longer rapid eye movement (REM) episodes, night-
mares in PTSD can occur during both REM and non-
REM sleep [28]. Physiological changes, such as increases 
or fluctuations in heart and respiratory rate, can lead to 
awakening if significantly pronounced, and these events 
are often associated with nightmare awakenings. Typi-
cally, affected patients are fully oriented quickly despite 
marked anxiety symptoms.





Although video polysomnography (PSG) is not a stan-
dard diagnostic tool for PTSD-associated sleep disorders, it 
may be indicated for the diagnosis of comorbid-specific 
sleep disorders, such as sleep-related breathing disorders 
(SRBD) or parasomnia (e.g., a behavioral disorder in REM 
sleep) [29]. Compared to healthy controls, sleep studies in 
patients with PTSD show partially heterogeneous results in 
overall sleep continuity and sleep architecture depending 
on the time of the examination (acute vs. chronic PTSD), 
psychiatric comorbidities (especially major depression), 
and age. With respect to non-REM sleep, an increase in 
light sleep (stage 1) and a decrease in slow-wave sleep (SWS) 
may be found (overview in [30, 31]). More consistent al-
terations, however, are observed in REM sleep, character-
ized by a fragmentation with a higher number of transitions 
from REM sleep to stage 1 or awake state [32]. In addition, 
an increased REM sleep pressure – a shortening of REM 
latency (time between falling asleep and the first REM epi-
sode) and a higher REM density (number of rapid eye 
movements) – has been reported [30, 32].
The current body of research suggests that individuals 
with PTSD typically exhibit low parasympathetic tone 
during awake-resting states, resulting in an elevated 
mean heart rate (HR) and reduced cardiac reactivity. 
During sleep, however, increased sympathetic activation 
characteristically occurs in PTSD patients and is ob-
served primarily during REM sleep, resulting in in-
creased HR and decreased reactivity [33]. One older 
study demonstrated that altered nocturnal heart rate 
variability (HRV) was predictive of the development of 
PTSD in traumatized patients [34]. This relationship was 
confirmed in further studies and is now considered es-
tablished [33]. In addition, a study has shown that pre-
traumatic pathological HRV increases the risk of devel-
oping PTSD after trauma [35]. One study showed that 
elevated autonomic nervous system arousal indexed by 
HR with PTSD might be specific to the early part of sleep 
and that PTSD is possibly associated with impairment in 
regulating autonomic nervous system activity related to 
REM sleep [36].
A promising approach for gaining insight into the un-
derlying pathophysiological mechanisms of PTSD and 
disturbed sleep is the topographic spectral analysis of 
sleep EEG. A recent study demonstrated alterations in 
EEG spectral topologies during non-REM and REM 
sleep that correlated positively with nightmare activity 
and insomnia. Based on these findings, a spectral index 
was developed to differentiate between patients and con-
trols, thus serving as a candidate biomarker [37]. More-
over, a strong correlation of sleep EEG coherence mark-
ers with the diagnosis and severity of PTSD has been re-
ported [38]. Studies using high-density EEG markers 
have demonstrated reduced sleep depth indicated by re-
duced centro-parietal non-REM delta power and in-
creased gamma power in the anterofrontal regions dur-
ing both non-REM and REM sleep, indicating high-
arousal levels in patients with PTSD. These alterations 
were replicable across consecutive nights and subpopu-
lations [39]. Similar findings were reported in a recent 
study on sleep and emotion processing in pediatric 
PTSD, revealing a marked decrease in slow-wave activity 
and an increase in EEG gamma power during non-REM 
sleep in the patient group compared to healthy controls. 
In addition, a correlation between slow-wave activity 
power and affective habituation was most significant in 
a frontal cluster, indicating the importance of SWS for 
emotional processing in adolescence [40]. Sleep spindles 
are associated with sleep protection and sleep-dependent 
memory consolidation [41]. Recent studies demonstrat-
ed alterations in sleep spindle frequency and interchan-
nel phase differences possibly reflecting defective senso-
ry-gating mechanisms and thalamocortical circuits in 
patients with PTSD [42, 43]. It remains to be clarified 
whether these neurophysiological candidate biomarkers 
are suitable parameters for diagnosis or follow-up assess-
ments under treatment. Interestingly, a study of idio-
pathic nightmares demonstrated that early childhood 
adversity was associated with adult nightmare severity 
Table 1. Subtypes of post-traumatic nightmares (abbreviated [27])
Post-traumatic dream Post-traumatic nightmare Nonreplicate post-traumatic nightmare Replicative post-traumatic 
nightmare
Trauma-related dream content Frightening dream that leads 
to awakening
Content can be trauma-related, but does 
not represent the trauma





and disruption in basic sleep spindle expression, suggest-
ing pathophysiological mechanisms similar to those of 
PTSD nightmares [44]. Blaskovich et al. [45] found an 
increased number of arousals in individuals with fre-
quent nightmares, reflecting hyperarousal during pre-
REM periods; the authors further emphasized that anal-
yses of arousals should focus specifically on state transi-
tory periods.
Sleep and Emotion Regulation
Sleep disturbances are thought to play a mechanistic 
role in the emotional memory and learning model of 
PTSD. This postulates maladaptive fear conditioning, ex-
tinction learning, extinction memory, and safety learning 
as central mechanisms of PTSD. Following a traumatic 
event, an acute stress response may lead to sleep distur-
bances that may facilitate fear learning. Efficient fear ex-
tinction results in a downscaling of the stress system. If 
these processes are maladaptive, a trauma may lead to 
PTSD. While healthy sleep promotes resilience, sleep dis-
turbances favor the development and maintenance of 
PTSD [22] (Fig. 1). In animal studies in mice, it has been 
shown that trauma-associated sleep disturbances were as-
sociated with electrophysiological parameters of im-
paired memory acquisition, consolidation, and recall 
[46], corroborating clinical findings.
Human and animal sleep studies indicate that REM 
sleep plays an essential role in the processing of emotion-
al and traumatic events. It has been postulated that under 
the special neurochemical conditions of normal REM 
sleep (i.e., low adrenergic activity combined with high 
cholinergic activity), traumatic events are transformed 
into less stressful memory content (overview in [47]). 
This process is hypothesized to be altered in PTSD, as re-
flected by fragmented REM sleep. Accordingly, a recent 
functional MRI study showed that the amygdala respon-
siveness decreased proportionally to the duration of con-
solidated REM sleep, whereas experimentally induced 
“restless” REM sleep impaired amygdala adaptation in 
healthy subjects [48]. A constellation of fragmented REM 
sleep with excessive adrenergic neurotransmission and 
reduced activity of the medial prefrontal cortex may also 
lead to maladaptive consolidation of traumatic memory 
content [49] and promote the development of PTSD [22]. 
Acute REM sleep changes after stress exposure have also 
been demonstrated in rats. These changes were signifi-
cantly correlated with impaired fear-associated memory 
processing and the onset of PTSD-like symptoms [50]. 
Risk factors (e.g., sleep disturbances)
Stress response
PTSD











Fig. 1. Hypothesized interrelation between trauma, sleep disturbances, and PTSD. PTSD, post-traumatic stress 
disorder.




Recently, it has been reported that SWS may also play a 
role in adaptive emotional processing. In a study of chil-
dren with PTSD, impairments in slow-wave activity were 
correlated with reduced affective habituation [40]. Espe-
cially in the field of emotion regulation and the neurobi-
ology of processing traumatic memory content, experi-
mental sleep research can provide new insights that aim 
at specific sleep interventions as preventive measures 
[51]. Animal studies have yielded mixed results; in a ro-
dent model, optogenetically induced prolongation of 
sleep duration after trauma exposure led to a significant 
improvement in fear-associated memory processing, 
suggesting a beneficial effect on PTSD symptoms [52]. In 
contrast to these findings, prior studies in rodents pro-
vided evidence that preventing sleep in the early after-
math of trauma resulted in attenuated trauma stress re-
sponses [53, 54].
Comorbid Sleep Disorders
Apart from insomnia and nightmares, additional sleep 
disorders may frequently co-occur in patients with PTSD 
(Table 2). Factors mediating this association are largely 
unknown. Studies on the prevalence of SRBD and PTSD 
reveal highly mixed results. However, there is a concur-
rence that individuals with PTSD have a disproportion-
ately higher rate of SRBD, such as upper airway resistance 
and obstructive sleep apnea syndrome (OSAS) than the 
general population [55]. Consequently, patients with 
PTSD are more likely to suffer from hypertension, dyslip-
idemia, and diabetes. It is hypothesized that post-trau-
matic sleep fragmentation adversely influences the air-
way and increases vulnerability to the subsequent devel-
opment of OSAS, which in turn might worsen PTSD 
symptoms through further sleep fragmentation [55]. Ac-
cordingly, an association between effective OSAS treat-
ment and reduced PTSD severity has been found [66, 67]. 
Untreated OSAS may exacerbate sleep-related symp-
toms, including nightmares, insomnia, and daytime 
sleepiness. Interestingly, a recent study in otherwise 
healthy patients revealed that OSAS was associated with 
a significantly lower sleep spindle density in SWS and a 
shorter spindle duration in sleep stage 2 [68]. Given the 
changes in spindle characteristics in patients with PTSD, 
these findings support further investigations in the basic 
pathophysiological mechanisms underlying the associa-
tion between SRBD and PTSD.
Previous studies have also reported that prevalence 
rates of REM sleep behavior disorder (RBD) are higher in 
psychiatric disorders in general [69] and particularly in 
PTSD [60–64]. RBD is characterized by violent dream en-
actment behavior due to a loss of REM sleep atonia. The 
underlying pathophysiology of this disorder remains un-
clear; however, the use of antidepressants altered neu-
rotransmitter metabolism and intense nightmares may 
play a role [70]. The use of selective serotonin reuptake 
inhibitors (SSRIs) has been reported to be associated with 
REM sleep without atonia but not full-blown RBD [71]. 
Moreover, there is evidence that SSRIs can exacerbate 
REM sleep without atonia in psychiatric patients both 
with pre-existing RBD and without RBD [72]. The clini-
cal significance of RBD symptoms in PTSD is undisputed 
[73], and a recent study has shown that their occurrence 
is an indicator for the consolidation of intrusive memo-
ries [74]. RBD, OSAS, and other comorbid sleep disor-
ders, such as pavor nocturnus and nocturnal panic at-
tacks, should be included in the differential diagnosis of 
nightmares, namely because the available specific treat-
ment options may lead to a further improvement in sleep 
quality. Periodic limb movement disorder (PLMD) has 
also been found more frequently in patients with PTSD; 
however, the mechanism of this association remains un-
clear [60, 65]. It has repeatedly been shown that seroto-
nergic agents, such as Mirtazapine or SSRIs, which are 
also used to treat PTSD, can exacerbate or trigger PLMD 
[75, 76]; however, systematic studies in the context of 
PTSD are lacking.
Trauma-Associated Sleep Disorder
First described in 2014, trauma-associated sleep disor-
der (TSD) is characterized by a constellation of parasom-
nia symptoms and is thought to result from a trauma 
without the presentation or development of full PTSD 
[77]. There is evidence that the time of traumatization 
(childhood vs. adolescence/adulthood) may influence the 
Table 2. Comorbid sleep disorders in PTSD
SRBD [55, 56]




PTSD, post-traumatic stress disorder; REM, rapid eye 
movement; SRBD, sleep-related breathing disorder; RBD, REM 
sleep behavior disorder; PLMD, periodic limb movement disorder.
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manifestation of sleep disorders (adulthood trauma is 
more likely to lead to nightmares, whereas childhood 
trauma is more likely to lead to acting out dreams) [78]. 
The obligatory diagnostic criteria postulated by Mysli-
wiec et al. [27] are summarized in Table 3.
Whether TSD is a separate pathology, remains under 
debate among experts [70, 73, 79]. Interestingly, TSD and 
RBD share some clinical features such as dream enacting 
behavior. However, the differential diagnosis of both dis-
orders is important, as treatment with clonazepam is ef-
fective in RBD but not TSD [80]. Longitudinal studies are 
necessary to clarify whether TSD is consistently associ-
ated with loss of REM sleep atonia and to determine the 
risk of transition to neurodegenerative synucleinopathies 
[79].
PTSD, Sleep, and Suicidality
Chronic severe sleep disturbances and nightmares are 
a risk factor for suicidal behavior independently of any 
other comorbid mental illness [81]. The association of 
sleep disturbances with increased suicidality is seen in ad-
olescents [82, 83] and the elderly [84]. Self-injurious be-
havior has also been linked to sleep disturbances [85], 
with these being thought to play a mediating role between 
PTSD and self-injury [86]. A recent systematic review 
concluded that both sleep disturbances, such as low sleep 
efficiency, and increased HR are associated with suicidal-
ity [87]. Autonomic dysfunction (including nocturnal 
symptoms), such as altered HR or HRV, is well estab-
lished in the context of PTSD [33, 88]. A study of trauma-
tized individuals demonstrated that a standard index of 
autonomic activity (low-frequency/high-frequency ratios 
in the HRV index) was predictive of the extent of PTSD 
symptoms and also of suicidality [89]. On the other hand, 
PTSD is in itself a risk factor for suicidality [90, 91]. Al-
though sleep disorders and PTSD are established risk fac-
tors for suicidality and, conversely, the reciprocal influ-
ence of sleep and PTSD is well established, little is known 
about the complex interplay between sleep, PTSD, and 
suicidality. A recent review of the literature revealed in-
consistent study results due to different patient demo-
graphics, target parameters, and methodological short-
comings [92]. A longitudinal study including a large 
number of US soldiers showed that insomnia before mil-
itary service is predictive for the development of PTSD 
and suicidal thoughts after service [7]. However, when 
looking at all relevant studies, the question of an increased 
risk of suicidal behavior due to sleep disorders in the con-
text of PTSD cannot be answered conclusively. This 
would, however, be of importance insofar as targeted 
treatment of sleep disorders and nightmares could con-
tribute to reducing the risk of suicidality in PTSD patients 
[93].
Treatment
The primary goal of sleep- and nightmare-focused 
therapy is an effective reduction of nocturnal symptoms, 
which may also lead to an improvement in daytime well-
being [17–19]. Similarly, trauma-focused therapy can 
also positively influence sleep-related symptoms [94], 
and synergistic effects can be achieved with regard to 
PTSD symptoms [26]. However, there is a lack of con-
cepts in clinical practice that equally integrate day- and 
night-time symptoms into the treatment [95]. In particu-
lar, psychiatric comorbidities have to be taken into ac-
count for the development of multimodal therapy con-
cepts.
Psychotherapy
The first choice of treatment for chronic insomnia is 
disorder-specific cognitive behavioral therapy for insom-
nia (CBT-I) [96, 97], comprising treatment modules that 
Table 3. Trauma-associated sleep disorder (obligatory criteria, abbreviated [27])
Onset after traumatic experiences
A history of altered dream mentation that is related to prior traumatic experience
Disruptive nocturnal behaviors, including at least abnormal vocalizations (e.g., yelling or screaming) or abnormal motor behaviors 
(e.g., violent behavior in sleep)
Symptoms of autonomic hyperarousal or PSG monitoring (e.g., tachycardia and tachypnea)
PSG may demonstrate: RSWA or dream enactment behavior in REM sleep
Absence of epileptic EEG activity in PSG
PSG, polysomnography; REM, rapid eye movement; RSWA, REM sleep without atonia.




are also successfully used for PTSD-associated insomnia 
(Table 4) [98]. Effective techniques for the treatment of 
post-traumatic nightmares include Imagery Rehearsal 
Therapy (IRT) and Exposure, Relaxation, and Rescript-
ing Therapy (ERRT), as well as Exposure Therapy and 
Eye Movement Desensitization and Reprocessing 
(EMDR) therapy. The basic principle of IRT is a modifi-
cation of the nightmare into less stressful dream content. 
The patient replaces the traumatizing situation with new, 
positive images. The modified scenario is then practiced 
several times during the day in order to implement the 
new imaginative “script” in the dreams [99]. Meta-analy-
ses suggest that IRT is the most effective treatment for 
post-traumatic and idiopathic nightmares [26, 100]. IRT 
via the Internet seems to be similarly effective [101]. 
ERRT combines psychoeducational elements with imag-
inatively altered nightmares [102] and may also be effec-
tive in an abbreviated form [19]. It can also be used to 
treat residual nightmares after regular PTSD treatment 
[103]. In addition, ERRT was also shown to reduce sui-
cidal ideation, although this effect did not remain after 
controlling for PTSD and depression [104]. Within the 
framework of exposure therapy, the traumatizing event is 
recalled in as much detail as possible under the guidance 
of a therapist and processed step by step [105]. EMDR 
therapy is characterized by bilateral sensory stimulation 
(induced eye movements and touching of the hands) 
while recalling distressing images; this stimulates new 
processing and integration of traumatic experiences, es-
pecially on a sensory-somatic level, which can lead to a 
reduction in the intensity of nightmares [106]. There is 
also a trend to combine different treatments and to de-
velop therapies tailored to specific target groups. For ex-
ample, in a case series of patients with PTSD, the combi-
nation of CBT-I and IRT was shown to be effective in 
treating nightmares and insomniac symptoms [107]. In a 
pilot study, the combination of CBT-I and prolonged ex-
posure proved effective in reducing insomnia and PTSD 
[108]. Special therapy programs have been developed and 
successfully used for veterans with PTSD and depression 
who had residual nightmares and insomnia [109]. An-
other example in this context is Firefighter’s Therapy for 
Insomnia and Nightmares, which combines brief CBT-I 
with elements of IRT [110]. Lucid dreaming may also be 
used [111], but a reduction of PTSD-associated night-
mares could not be demonstrated in a recent study [112]. 
The conclusiveness of this study, however, is limited due 
to various factors (i.e., low number of cases and high 
dropout rate). It is a great challenge to develop effective 
protocols for the induction of lucid dreaming, since only 
about 50% of all people have the basic ability to lucid 
dream, and only about 20% of them dream lucidly with 
some regularity [113].
Pharmacotherapy
In clinical practice, PTSD-associated insomnia is often 
treated using sedative antidepressants (e.g., mirtazapine, 
doxepin, trimipramine, and amitriptyline) or sedative 
atypical antipsychotics (e.g., quetiapine). However, the 
evidence is limited, given the small number of studies and 
the potential side effects, especially when treatment over 
a longer period is required [114–117]. Z-drugs (zolpidem 
and zopiclone) or benzodiazepines may be used in the 
short-term (2–4 weeks) treatment of insomnia [96]. Due 
to their addictive potential, these drugs should be used 
with caution, and long-term treatment should be avoid-
ed, especially considering that the risk of dependency 
seems to be increased in patients with PTSD [118]. Inter-
estingly, an altered benzodiazepine receptor-binding 
profile in patients with PTSD has been reported in a func-
tional neuroimaging study [119]. In the current guide-
lines of the American Academy of Sleep Medicine 
(AASM), single drugs are evaluated with regard to their 
efficacy and benefit-risk profile. No recommendation for 
single drugs in the treatment of insomnia is higher than 
“weak.” A “weak” recommendation represents lower cer-
tainty in the appropriateness of the treatment strategy for 
all patients, but this is not an indicator of ineffectiveness 
[120]. Among antidepressants, only doxepin and trazo-
done are evaluated in the guidelines; quetiapine is the 
Table 4. Cognitive behavioral therapy for insomnia (CBT-I)
Modules Methods
Psychoeducation Information on sleep and sleep disorders; sleep hygiene recommendations
Relaxation techniques Progressive muscle relaxation, mindfulness, yoga, and meditation
Sleep restriction Limiting the amount of time spent in bed to an amount equal to sleep time
Stimulus control Reconditioning the bed and bedroom as strong cues for sleep
Cognitive therapy Cognitive restructuring of dysfunctional beliefs and attitudes about sleep
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only antipsychotic listed, but no recommendation is giv-
en due to the paucity of data.
Drug treatment of post-traumatic nightmares is a mat-
ter of controversial discussion. In recent years, prazosin 
(α1 adrenergic receptor antagonist) has increasingly be-
come the focus for drug treatment. Initially, randomly 
observed in the treatment of hypertension, the efficacy of 
prazosin on PTSD-associated nightmares has been shown 
in several randomized studies [121]. As a result, the 
AASM initially recommended the use of prazosin for the 
treatment of PTSD-associated nightmares [122]. In 2018, 
however, a multicenter randomized study could not con-
firm the favorable results [123], leading to the recommen-
dation level being downgraded to “may be used” by the 
AASM [100], decision which has raised some concerns by 
other authors [124]. Recent meta-analyses revealed that 
prazosin is effective in the treatment of post-traumatic 
nightmares, whereas its effects on sleep quality and PTSD 
symptoms in general are less favorable [125, 126]. Inter-
estingly, a recent study has shown that prazosin was as-
sociated with an increased risk of OSAS [127], finding 
that may help to explain why some patients do not expe-
rience an increase in their sleep quality [128]. Prazosin is 
not available in some European countries. Alternatively, 
doxazosin or terazosin (also α1-antagonists but with dif-
ferent pharmacodynamics) may be used [129]. For sub-
stances with different mechanisms of action, the evidence 
regarding their effectiveness in the treatment of post-
traumatic nightmares is limited [100]. The pharmacolog-
ical treatment of post-traumatic nightmares is summa-
rized in Table 5.
Because there are no official recommendations for any 
of the substances, they should be used only following a 
strict risk-benefit analysis, especially considering that 
their use would be considered off-label. Specifically, the 
noradrenergic-serotonergic reuptake inhibitor venlafax-
ine and the benzodiazepine clonazepam exert no effect on 
nightmares in PTSD, and their use is explicitly discour-
aged [100]. It should also be taken into account that sero-
tonergic antidepressants in particular may induce or in-
tensify nightmares [130]. In the context of a change or 
adjustment of medication, it may be helpful to monitor 
the frequency and intensity of nightmares. Preliminary 
results of medically prescribed cannabis for trauma-relat-
ed nightmares seem to be promising [131]; however, the 
evidence to date for this indication is low [132]. In the 
case of pharmacological treatment of sleep-related target 
symptoms, concomitant somatic diseases, such as arterial 
hypertension or neuropathic pain should also be consid-
ered to avoid polypharmacy.
Integrating Sleep Disorders in a Broader PTSD-
Treatment Concept
Improvement of symptoms at night might also be ac-
companied by an amelioration of PTSD symptoms dur-
ing the day [17–19]. Conversely, residual sleep disorders 
may contribute to the maintenance of PTSD if they are 
not adequately treated [15, 16]. Therefore, a close integra-
tion of different interventions for day and night symp-
toms in the sense of an integrative concept would be de-
sirable [95]. Moreover, the implementation of specific 
techniques, such as CBT-I, ERRT, EMDR, and IRT in a 
broader PTSD-treatment concept requires adequate 
knowledge of corresponding methods or experience in 
the treatment of sleep disorders. Further studies are need-
ed comprising medical, psychological, and sociocultural 
factors to establish optimized-treatment algorithms [95].
Sleep Interventions in the Early Aftermath of Trauma
Whether an early effective treatment of sleep disorders 
and nightmares can mitigate or even prevent the develop-
ment of full PTSD remains to be clarified. However, sleep 
interventions after traumatic events, such as sleep facilita-
tion and targeted sleep deprivation have been discussed 
Table 5. Pharmacological treatment of post-traumatic nightmares*
Substance groups Substances
Antihypertensives Prazosin, doxazosin, terazosin, and clonidine
Atypical neuroleptics Olanzapine, risperidone, and aripiprazole
Antidepressants Trazodone, fluvoxamine, and tricyclics
Antihistamines Cyproheptadine
Anticonvulsants Gabapentin and topiramate
Synthetic cannabinoids Nabilone
* Note that the evidence for all substances listed here is low (“may be used”) [100].




as possible therapeutic approaches [133]. Already in 
2006, theoretical considerations led to the suggestion that 
sleep deprivation immediately after a traumatic event 
could prevent the transition to PTSD [134]. Because it is 
rarely possible to study sleep so shortly after a traumatic 
event, the so-called trauma film paradigm (an experi-
mental model for traumatic events) was developed. By 
exposing participants to analog trauma (film-represent-
ing traumatic experiences), researchers are able to study 
immediate effects of trauma and the effects of treatments 
on the re-experience of trauma and other PTSD symp-
toms [135]. Using this method, it was reported [134] that 
sleep deprivation immediately after an induced trauma 
led to fewer intrusions [136]. These findings contrast with 
results from another study with rare and mild intrusive 
memories after sleep episode following an experimental 
trauma [137]. A subsequent study found no significant 
group difference of intrusive symptoms in the week fol-
lowing a trauma film [138]. Additional experimental 
studies have demonstrated that longer REM sleep dura-
tion was associated with reduced PTSD severity, and 
higher REM theta activity with fewer intrusive memories 
[139]; furthermore, napping was associated with fewer 
intrusive memories [140]. Overall, these studies provide 
some evidence for a possible protective role of sleep after 
(experimentally induced) trauma in the development of 
intrusive symptoms and PTSD [133]. Naturalistic studies 
have found that sleep disorders directly following a trau-
matic event may increase the risk for the development 
and increased severity of PTSD [133]. In addition, sleep 
disturbances in the first week after a trauma correlated 
with the extent of intrusive symptoms [141]. In particu-
lar, sleep in the first night following trauma may be cru-
cial, and both too little and too much sleep was found to 
promote intrusive symptoms [142]. Taken together, re-
search on targeted sleep interventions has revealed het-
erogeneous results requiring further study. The use of 
home-based PSG immediately after a traumatic event 
may be a promising approach to gain further insights into 
the complex relationship between sleep and PTSD [51].
Conclusions and Future Directions
The present review summarizes the existing literature 
on the clinical features and treatment options of sleep dis-
orders in patients with PTSD. We emphasize that sleep 
and PTSD are strongly interrelated in a bidirectional 
manner. Persistent sleep problems are an important 
prognostic factor for the development and severity of 
PTSD. Therefore, a targeted exploration of sleep distur-
bances, including the recognition of comorbid-specific 
sleep disorders, such as OSAS and parasomnias, is essen-
tial. As sleep disturbances may emerge as prodromes of 
PTSD, this applies also to people who have been exposed 
to a traumatic event. An effective treatment of sleep dis-
orders and nightmares may not only improve symptoms 
at night but also daytime well-being and quality of life. 
Overall, there is robust evidence for the effectiveness of 
behavioral therapy methods and less evidence for phar-
macological treatment. Identifying subgroups of patients 
with PTSD, who benefit from drug treatment to a greater 
extent is of great interest. In addition, integrative con-
cepts and optimized treatment algorithms for sleep and 
daytime symptoms are needed. Adequate therapy might 
also reduce the risk of suicidality in these patients; how-
ever, the complex interactions between PTSD, sleep, and 
suicidality are not well understood and should be inves-
tigated in more detail. We have also reviewed the growing 
literature on the macro- and microstructure of sleep us-
ing PSG and quantitative high-density EEG analyses. Al-
though promising results have been published, it still has 
to be clarified whether EEG spectral topologies may serve 
as biomarkers in PTSD. Future studies should also make 
efforts to clarify the effects of sleep alterations on emo-
tional processing and traumatic memories. Specifically, 
experimental research can provide new insights that aim 
at specific sleep interventions as preventive measures for 
PTSD [51].
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